As of Apr 26
| -0.50 / -1.14%|
The 12 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 60.50, with a high estimate of 106.00 and a low estimate of 34.00. The median estimate represents a +39.14% increase from the last price of 43.48.
The current consensus among 13 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.